Merck & Co., Inc: all 2,453 studies
Page 24 of 25. Open to participants first (145), then studies with results posted, then the rest; newest registration first within each.
- Dose Escalation Study of KW-3902 on Diuresis in Subjects With Congestive Heart Failure (CHF).CompletedNCT00159627Phase 2
- Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal ImpairmentCompletedNCT00159614Phase 2
- A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)CompletedNCT00157898Phase 4
- A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)CompletedNCT00157872Phase 4
- Comparison of Osteoporosis Disease Management Strategies (0000-039)CompletedNCT00145080Not applicable
- Osteoporosis Disease Management Demonstration Project (0000-040)CompletedNCT00145067Not applicable
- A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff SyndromeTerminatedNCT00140933Phase 3
- A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)TerminatedNCT00140920Phase 4
- A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)TerminatedNCT00140894Phase 4
- Tiotropium Bromide Alone vs Tiotropium Bromide and Formoterol Fumarate in Subjects With COPD (Study P04272)CompletedNCT00139932Phase 4
- Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)CompletedNCT00139438Not applicable
- Osteoporosis Disease Management Demonstration Project (0000-037)CompletedNCT00139425Not applicable
- Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard AntibioticsCompletedNCT00136292Phase 1
- A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular EdemaWithdrawnNCT00135655Phase 2
- Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain SubjectsCompletedNCT00135577Phase 2
- Safety of SCH 530348 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention (Study P03573)CompletedNCT00132912Phase 2
- An Eighteen Month Efficacy and Safety Study in Obese Patients (0364-020)(COMPLETED)CompletedNCT00131430Phase 2/3
- A Two Year Safety and Efficacy Study in Obese Patients (0364-015)(TERMINATED)TerminatedNCT00131404Phase 3
- A Study of MK0364 in Obese Patients (0364-014)TerminatedNCT00131391Phase 3
- An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065)TerminatedNCT00130806Phase 3
- A Study in Pediatric Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00130182Phase 2
- Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032)TerminatedNCT00128115Phase 2
- A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)CompletedNCT00127153Phase 3
- A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030)CompletedNCT00127140Phase 1
- A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Relapsed or Refractory Breast, Colorectal and Non-Small Cell Lung Cancer (0683-011)(TERMINATED)TerminatedNCT00126451Phase 2
- A Study to Compare Different Intubating Doses of Zemuron in Pediatric and Adolescent Subjects Under General AnesthesiaCompletedNCT00124722Phase 3
- AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)CompletedNCT00122343Phase 2
- Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard TherapyCompletedNCT00120861Phase 2
- Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis CCompletedNCT00120835Phase 1/2
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis CCompletedNCT00118768Phase 2
- MARS - Monitored Atherosclerosis Regression StudyCompletedNCT00116870Phase 2/3
- Study to Treat Uveitis Associated Macular EdemaTerminatedNCT00114062Phase 2
- Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)CompletedNCT00112372Phase 1
- An Investigational Drug Study Evaluating a Novel Approach to Treat Dyslipidemia (0524A-032)CompletedNCT00111891Phase 2
- MK0457 in Patients With Leukemia (0457-003)CompletedNCT00111683Phase 1
- Ridaforolimus (AP23573/MK-8669) in Participants With Taxane-Resistant Androgen-Independent Prostate Cancer (AIPC)(MK-8669-017)CompletedNCT00110188Phase 2
- Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)TerminatedNCT00109538Phase 3
- A Measles, Mumps, and Rubella Investigational Vaccine Trial (V205C-010)(COMPLETED)CompletedNCT00109278Phase 2
- An Investigational Drug Study in Obese (Considerably Overweight) Patients (0364-006)CompletedNCT00109148Phase 2
- A Study to Investigate a Research Drug as an Aid for Smoking Cessation in Chronic Cigarette Smokers (0364-007)CompletedNCT00109135Phase 2
- Safety, Tolerability, and the Body's Ability to Develop Resistance to an Investigational Vaccine for Shingles (V211-007)CompletedNCT00109122Phase 2
- A Clinical Trial of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Advanced Multiple Myeloma (0683-004)TerminatedNCT00109109Phase 1
- Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED)CompletedNCT00108017Phase 3
- A Notch Signalling Pathway Inhibitor for Patients With Advanced Breast Cancer (0752-014)CompletedNCT00106145Phase 1
- A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)CompletedNCT00104364Phase 1
- Study of Denufosol Tetrasodium in Patients With Cystic Fibrosis Lung DiseaseCompletedNCT00103714Phase 2
- Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure InfectionsTerminatedNCT00102947Phase 4
- ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic CancerCompletedNCT00102700Phase 2
- Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain MedicationCompletedNCT00101998Phase 2
- A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)TerminatedNCT00100152Phase 1
- Study of the Tolerability, Pharmacokinetics, and Pharmacodynamics of INS50589 Intravenous Infusion in Healthy VolunteersCompletedNCT00099450Phase 1
- MK0457 (an Aurora Kinase Inhibitor) Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors (0457-001)TerminatedNCT00099346Phase 1
- ARQ 501 in Combination With Docetaxel in Patients With CancerCompletedNCT00099190Phase 1
- An Investigational Drug Study With Suberoylanilide Hydroxamic Acid in Relapsed Diffuse Large B-cell Lymphoma (0683-013)CompletedNCT00097929Phase 2
- OPT-80 in Clostridium Difficile-Associated Diarrhea (CDAD)CompletedNCT00097422Phase 2
- Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)CompletedNCT00093080Phase 2
- Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. AureusCompletedNCT00093067Phase 3
- A 1-Year Study of an Investigational Drug in Obese Patients (0557-012)(COMPLETED)CompletedNCT00092872Phase 3
- A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)CompletedNCT00092859Phase 3
- A 6-Month Consumer Behavior Study of a Self-Management System (0803-084)(COMPLETED)CompletedNCT00092846Phase 3
- Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)CompletedNCT00092482Phase 3
- Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)CompletedNCT00092469Phase 3
- Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
- Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)CompletedNCT00092404Phase 2
- A Study of An Approved Vaccine at Mumps Expiry Potency in Healthy Children 12 to 18 Months of Age (V205C-007)(COMPLETED)CompletedNCT00092391Phase 3
- A Study of Two Approved Drugs in the Treatment of Post-Bunionectomy Surgery Pain (0966-234)(COMPLETED)CompletedNCT00092378Phase 3
- A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)CompletedNCT00092365Phase 3
- A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)CompletedNCT00092352Phase 3
- A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-190)(COMPLETED)CompletedNCT00092339Phase 3
- A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-183)CompletedNCT00092326Phase 3
- A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-182)CompletedNCT00092313Phase 3
- A Study of Two Approved Drugs in the Treatment of Postoperative Dental Pain (0966-181)(COMPLETED)CompletedNCT00092300Phase 3
- Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)CompletedNCT00092196Phase 3
- An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)CompletedNCT00092183Phase 4
- An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)CompletedNCT00092170Phase 2
- A Study of MK0217A and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)CompletedNCT00092079Phase 3
- Oral SAHA (Suberoylanilide Hydroxamic Acid) in Advanced Cutaneous T-cell Lymphoma (0683-001)CompletedNCT00091559Phase 2
- A Single Dose of a Marketed Drug Being Studied for a New Indication to Treat Surgical Site Infection Following Colorectal Surgery as Compared to a Marketed Drug Approved for This Indication (0826-039)CompletedNCT00090272Phase 3
- 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-091)CompletedNCT00090246Phase 3
- Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV) Associated With Highly Emetogenic Chemotherapy (0869-801)(COMPLETED)CompletedNCT00090207Phase 4
- 2 Doses of an Approved Drug Being Studied for a New Indication for the Prevention of Postoperative Nausea and Vomiting (0869-090)(COMPLETED)CompletedNCT00090155Phase 3
- Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)CompletedNCT00087451Phase 1
- Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)CompletedNCT00086125Phase 2
- Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal DetachmentTerminatedNCT00083967Phase 2
- Caspofungin for the Treatment of Non-blood Candida Infections (0991-045)CompletedNCT00083343Phase 2
- MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)CompletedNCT00082537Phase 2
- Documented Candida or Aspergillus Infections in Pediatric Patients (0991-043)CompletedNCT00082524Phase 2
- Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (P03480)CompletedNCT00081510Phase 2
- Study of Aprepitant (MK-0869) for Chemotherapy-Induced Nausea and Vomiting (CINV) in Adolescent Participants (MK-0869-097)CompletedNCT00080444Phase 3
- MK0991 in Combination With Standard Antifungal Agent(s) for the Treatment of Salvage Invasive Aspergillosis (0991-037)CompletedNCT00076869Phase 2
- Temozolomide for Treatment of Brain Metastases From Non-Small Cell Lung Cancer (Study P03247)CompletedNCT00076856Phase 2
- ARQ 501 in Subjects With CancerCompletedNCT00075933Phase 1
- Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED)CompletedNCT00074529Phase 2
- Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)TerminatedNCT00073450Phase 2
- Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)CompletedNCT00060645Phase 1
- Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)CompletedNCT00060632Phase 1
- A Safety and Efficacy Trial Evaluating the Use of Fondaparinux in Percutaneous Coronary Intervention (PCI)(63133)(WITHDRAWN)WithdrawnNCT00060554Phase 2
- Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)CompletedNCT00060476Phase 3
- Study of INS37217 Inhalation Solution in Mild to Moderate Cystic Fibrosis Lung DiseaseCompletedNCT00056147Phase 2
- Daptomycin for the Treatment of Infections Due to Gram-Positive BacteriaTerminatedNCT00055198Phase 3